propiconazole has been researched along with imatinib mesylate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, MA; Butler, CE; Esmaeli, B; Kantarjian, HM; Kim, SK; Prieto, VG; Talpaz, M | 1 |
| Dik, WA; Dingjan, GM; Drexhage, HA; Hooijkaas, H; Paridaens, D; Schrijver, B; van Daele, PL; van den Bosch, WA; van Hagen, PM; van Steensel, L | 1 |
| Dik, WA; Dingjan, GM; Drexhage, HA; Hooijkaas, H; Kuijpers, RW; Paridaens, D; van Daele, PL; van den Bosch, WA; van Hagen, PM; van Steensel, L | 1 |
| Fratianni, C; Gonzales, M; Khardori, R; Mamillapali, C | 1 |
| Dalm, VA; Dik, WA; Hirankarn, N; Paridaens, D; van den Bosch, WA; van Hagen, PM; Virakul, S | 1 |
| Sekine, T; Suzuki, K | 1 |
| Amin, A; Aslam, HM; Bashir, S; Hashmi, AS; Malik, B; Mumtaz, S; Tariq, M | 1 |
1 review(s) available for propiconazole and imatinib mesylate
| Article | Year |
|---|---|
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antioxidants; Asthma; Azathioprine; Benzamides; Complex Regional Pain Syndromes; Cyclosporine; Decompression, Surgical; Etanercept; Glucocorticoids; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Octreotide; Omalizumab; Orbit; Piperazines; Pyridones; Pyrimidines; Radiotherapy Dosage; Receptors, Tumor Necrosis Factor; Risk Factors; Rituximab; Selenium | 2012 |
6 other study(ies) available for propiconazole and imatinib mesylate
| Article | Year |
|---|---|
Severe periorbital edema secondary to STI571 (Gleevec).
Topics: Benzamides; Edema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Middle Aged; Orbit; Orbital Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2002 |
Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
Topics: Adult; Aged; Aged, 80 and over; Becaplermin; Benzamides; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Gene Expression Regulation; Glucuronosyltransferase; Graves Ophthalmopathy; Humans; Hyaluronan Synthases; Hyaluronic Acid; Imatinib Mesylate; Male; Middle Aged; Orbit; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta1 | 2009 |
Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
Topics: Adult; Aged; Angiogenesis Inducing Agents; Becaplermin; Benzamides; Cells, Cultured; Cytokines; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Lung; Male; Middle Aged; NF-kappa B; Orbit; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Skin | 2010 |
The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.
Topics: Becaplermin; Benzamides; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dasatinib; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Regulation; Glucuronosyltransferase; Graves Ophthalmopathy; Humans; Hyaluronan Synthases; Imatinib Mesylate; Interleukin-6; Interleukin-8; Orbit; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Pyrimidines; RNA, Messenger; Thiazoles | 2014 |
[A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
Topics: Aged; Antineoplastic Agents; Benzamides; Ecthyma; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Orbit; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines | 2014 |
Orbital dermatofibrosarcoma protuberans with intracranial extension preceded by recurrent leiomyoma of the orbit: a case report.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Combined Modality Therapy; Dermatofibrosarcoma; Eye Neoplasms; Humans; Imatinib Mesylate; Leiomyoma; Male; Middle Aged; Oncogene Proteins, Fusion; Orbit; Skin Neoplasms | 2015 |